Search for: "HI-TECH PHARMACAL CO., INC." Results 1 - 16 of 16
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Oct 2011, 9:59 pm by Patent Docs
Hi-Tech Pharmacal Co. [read post]
31 Mar 2015, 9:59 pm by Patent Docs
The case involved patentee Senju Pharmaceutical's (joined by Kyorin Pharmaceutical Co. and Allergan, Inc.) suit against Lupin Ltd., Lupin Pharmaceuticals, and Hi-Tech Pharmacal in response to a Paragraph IV certification against Senju's patented ocular antimicrobial agent containing the drug gatifloxacin as claimed in re-examined U.S. [read post]
13 Jan 2013, 9:06 pm by Patent Docs
• Defendants: Apotex Inc.; Apotex Corp.; Sandoz, Inc.; Hi-Tech Pharmacal Co., Inc.; Watson Pharmaceuticals, Inc.; Watson Laboratories, Inc.; Watson Pharma, Inc. [read post]
29 Mar 2007, 9:27 pm
By Sherri Oslick --- In a case testing the interplay between terminal disclaimers and patent term extensions under the Hatch-Waxman Act, the Federal Circuit, in affirming the judgment of the district court, held that patent term extensions could - nay should - be applied to terminally disclaimed patents, leaving Merck's... [read post]
2 Apr 2007, 11:46 pm
HI-TECH Pharmacal Co., Inc. (03/29/2007): this case presents the question of "whether a patent term extension under the Hatch-Waxman Act, 35 U.S.C. [read post]
18 Nov 2009, 4:57 am
(Patent Docs) Zolpimist (Zolpidem) - US: Hi-Tech Pharmacal's ECR subsidiary signs exclusive agreement to commercialise sleep aid in oral spray form (SmartBrief) [read post]
18 Nov 2009, 4:57 am
(Patent Docs) Zolpimist (Zolpidem) - US: Hi-Tech Pharmacal’s ECR subsidiary signs exclusive agreement to commercialise sleep aid in oral spray form (SmartBrief)   [read post]
18 Nov 2009, 4:57 am
(Patent Docs) Zolpimist (Zolpidem) - US: Hi-Tech Pharmacal's ECR subsidiary signs exclusive agreement to commercialise sleep aid in oral spray form (SmartBrief) [read post]
15 Jan 2015, 12:17 pm by Lawrence B. Ebert
” In re Seagate Tech., LLC, 497 F.3d 1360, 1371(Fed. [read post]
26 Jul 2011, 11:45 am by Josh Myers
The Food and Drug Administration approved a generic version of Levaquin made available by Hi-Tech Pharmacal Co. [read post]
18 Jan 2011, 3:10 am by Scott A. McKeown
Hi-Tech Pharmacal Co., Inc., 482 F.3d 1317, 1322-23 (Fed. [read post]
11 Jun 2010, 2:15 pm
PMR Techs., Ltd., 292 F.3d 1363, 1376-77 (Fed. [read post]
29 Aug 2008, 1:25 pm
– Discussion of IPFrontline.com article ‘Understanding Intellectual Property Value’: (IP finance), How to make sure your IP strategy plan is not doomed to failure: (IP Asset Maximizer Blog) Improve venture capital returns with IP portfolio management: (Ezine @rticles)   Global - Trade Marks / Domain Names / Brands Trade mark strategy – counterintuitive names: (IP Thinktank), ICANN Intellectual Property Constituency paper on sunrise mechanisms for… [read post]